Literature DB >> 25394594

Evaluation of a thermoprotective gel for hydrodissection during percutaneous microwave ablation: in vivo results.

Anna J Moreland1, Meghan G Lubner, Timothy J Ziemlewicz, Douglas R Kitchin, J Louis Hinshaw, Alexander D Johnson, Fred T Lee, Christopher L Brace.   

Abstract

PURPOSE: To evaluate whether thermoreversible poloxamer 407 15.4 % in water (P407) can protect non-target tissues adjacent to microwave (MW) ablation zones in a porcine model.
MATERIALS AND METHODS: MW ablation antennas were placed percutaneously into peripheral liver, spleen, or kidney (target tissues) under US and CT guidance in five swine such that the expected ablation zones would extend into adjacent diaphragm, body wall, or bowel (non-target tissues). For experimental ablations, P407 (a hydrogel that transitions from liquid at room temperature to semi-solid at body temperature) was injected into the potential space between target and non-target tissues, and the presence of a gel barrier was verified on CT. No barrier was used for controls. MW ablation was performed at 65 W for 5 min. Thermal damage to target and non-target tissues was evaluated at dissection.
RESULTS: Antennas were placed 7 ± 3 mm from the organ surface for both control and gel-protected ablations (p = 0.95). The volume of gel deployed was 49 ± 27 mL, resulting in a barrier thickness of 0.8 ± 0.5 cm. Ablations extended into non-target tissues in 12/14 control ablations (mean surface area = 3.8 cm(2)) but only 4/14 gel-protected ablations (mean surface area = 0.2 cm(2); p = 0.0005). The gel barrier remained stable at the injection site throughout power delivery.
CONCLUSION: When used as a hydrodissection material, P407 protected non-targeted tissues and was successfully maintained at the injection site for the duration of power application. Continued investigations to aid clinical translation appear warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25394594      PMCID: PMC6362984          DOI: 10.1007/s00270-014-1008-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

Review 1.  Microwave ablation in primary and secondary liver tumours: technical and clinical approaches.

Authors:  Maria Franca Meloni; Jason Chiang; Paul F Laeseke; Christoph F Dietrich; Angela Sannino; Marco Solbiati; Elisabetta Nocerino; Christopher L Brace; Fred T Lee
Journal:  Int J Hyperthermia       Date:  2016-08-02       Impact factor: 3.914

2.  Fibrillar collagen injection for organ protection during thermal ablation of hepatic malignancies.

Authors:  Bill S Majdalany; Jonathan Willatt; Jeffrey Forris Beecham Chick; Ravi N Srinivasa; Wael A Saad
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

3.  Prospective pilot study of CT-guided microwave ablation in the treatment of osteoid osteomas.

Authors:  Clara Prud'homme; Jean-Philippe Nueffer; Michel Runge; Jonathan Dubut; Bruno Kastler; Sébastien Aubry
Journal:  Skeletal Radiol       Date:  2016-12-27       Impact factor: 2.199

Review 4.  Liver microwave ablation: a systematic review of various FDA-approved systems.

Authors:  Simeon J S Ruiter; Wouter J Heerink; Koert P de Jong
Journal:  Eur Radiol       Date:  2018-11-30       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.